Seroprevalence of HBV and HCV markers among intravenous drug abusers and subjects affected by chronic active hepatitis.
In order to investigate the seroprevalence of HBV and HCV in neapolitan area, we studied blood specimens of 180 IVDAs, 115 CAH patients and 72 healthy subjects using hepatitis B core (anti-HBs) and hepatitis C antibody (anti-HCV). High frequency of anti-HBs (80.9%) and strong association with an unexpected seroprevalence of anti-HCV (67%) was found in CAH patients. Our study does not explain these results, but suggest either a possible inference between both viruses or that serum from CAH subjects contains a component that gives false positivity.
De Mercato
R
R
Istituto di Medicina Pubblica e della Sicurezza Sociale, II Facoltà di Medicina dell'Università di Napoli.
Ciampi
R
R
Romano
A
A
Guarnaccia
D
D
Siciliano
V
V
Cantiello
J P
JP
Rippa
O
O
Celentano
U
U
Selva
V
V
Romano
C
C
D000328:Adult; D015415:Biomarkers; D003430:Cross-Sectional Studies; D005260:Female; D006508:Hepatitis Antibodies / Q000032:analysis*; D006509:Hepatitis B / Q000150:complications / Q000453:epidemiology* / Q000276:immunology; D006526:Hepatitis C / Q000150:complications / Q000453:epidemiology* / Q000276:immunology; D006521:Hepatitis, Chronic / Q000276:immunology / Q000382:microbiology*; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D015819:Substance Abuse, Intravenous / Q000150:complications*
D015415:Biomarkers; D006508:Hepatitis Antibodies